Fortis Healthcare Sees Sharp Open Interest Surge Amidst Prolonged Downtrend

Open Interest Spike and Volume Dynamics

On 29 September 2026, Fortis Healthcare's open interest (OI) in derivatives rose sharply to 24,389 contracts from the previous 19,358, marking a 25.99% increase. This surge in OI was accompanied by a volume of 29,450 contracts, indicating heightened trading activity. The futures segment alone accounted for a value of approximately ₹16,217.67 lakhs, while the options segment's notional value stood at an impressive ₹16,740.90 crores, culminating in a total derivatives value of ₹19,739.47 lakhs.

The underlying stock closed at ₹778, hovering just 1.54% above its 52-week low of ₹766.8. This proximity to the annual low, combined with the spike in derivatives activity, suggests that market participants are positioning aggressively amid bearish sentiment.

Price Performance and Market Context

Fortis Healthcare has underperformed its sector, the Hospital & Healthcare Services, which itself declined by 4.33% on the day. The stock fell 5.37% on 29 September, opening with a gap down of 5.15% and touching an intraday low of ₹778.5, a 5.29% drop from the previous close. Notably, the stock has been on a six-day losing streak, shedding 13.13% over this period, reflecting sustained selling pressure.

Trading activity has been concentrated near the day's low, as evidenced by the weighted average price skewing towards the lower end of the intraday range of ₹1.15. This pattern indicates that sellers dominated throughout the session, with buyers reluctant to step in at higher levels.

Technical Indicators and Moving Averages

Technically, Fortis Healthcare is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — reinforcing the bearish trend. The stock's failure to reclaim these averages suggests weak momentum and a lack of short-term buying interest.

Investor participation has risen notably, with delivery volumes reaching 16.94 lakh shares on 29 September, a 92.86% increase compared to the five-day average. This surge in delivery volume indicates that more investors are holding positions despite the price decline, possibly reflecting accumulation by some participants or increased short selling.

Market Positioning and Potential Directional Bets

The pronounced increase in open interest alongside rising volumes amid a falling stock price typically signals that new positions are being initiated rather than existing ones being squared off. In Fortis Healthcare's case, the data suggests that market participants are increasingly taking bearish positions, possibly through futures shorting or put option buying, anticipating further downside.

The futures value of ₹16,217.67 lakhs and the substantial options notional value underscore the scale of derivatives trading, reflecting active hedging and speculative strategies. The options market, with a value exceeding ₹16,740 crores, is particularly significant, as it provides investors with flexible instruments to express directional views or hedge existing exposures.

Mojo Score and Analyst Ratings

Fortis Healthcare currently holds a Mojo Score of 44.0, categorised as a 'Sell' rating by MarketsMOJO. This represents a downgrade from its previous 'Hold' grade on 15 September 2026, signalling deteriorating fundamentals or technical outlook. The mid-cap stock, with a market capitalisation of ₹58,853 crores, faces headwinds both from sectoral weakness and company-specific challenges.

The downgrade aligns with the observed price weakness and derivatives activity, reinforcing the cautious stance investors should adopt. The stock's underperformance relative to the sector and the broader Sensex, which declined marginally by 0.07% on the same day, highlights its vulnerability.

Liquidity and Trading Considerations

Liquidity remains adequate for Fortis Healthcare, with the stock's traded value supporting a trade size of approximately ₹3.35 crores based on 2% of the five-day average traded value. This ensures that institutional and retail investors can execute sizeable trades without significant market impact, which is crucial given the heightened derivatives activity.

However, the narrow intraday trading range and the concentration of volume near the lows suggest limited upside interest in the near term. Investors should be wary of potential volatility spikes, especially if the stock breaches its 52-week low, which could trigger stop-loss orders and accelerate selling.

Implications for Investors

The confluence of a sharp rise in open interest, sustained price weakness, and increased delivery volumes paints a complex picture for Fortis Healthcare investors. While the derivatives market activity points to growing bearish bets, the rising delivery volumes may indicate some accumulation or hedging by long-term investors.

Given the current Mojo Grade downgrade and the stock's technical positioning below all major moving averages, investors should exercise caution. Those holding long positions might consider tightening stop-loss levels or reducing exposure, while traders could explore short-selling opportunities or protective put options to capitalise on the downtrend.

Sectoral weakness in Hospital & Healthcare Services further compounds the challenges, suggesting that any recovery in Fortis Healthcare will likely require broader sectoral support or company-specific positive developments.

Conclusion

Fortis Healthcare Ltd's recent surge in open interest and volume in the derivatives market amid a persistent downtrend highlights a shift in market sentiment towards bearish positioning. The stock's proximity to its 52-week low, combined with a downgrade to a 'Sell' rating and underperformance relative to its sector, underscores the risks ahead.

Investors should closely monitor derivatives activity and price action for signs of trend reversal or further deterioration. In the current environment, a cautious approach with a focus on risk management is advisable.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →